---
title: "Fresenius names Thomas Thestrup head of new Ventures unit"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293578816.md"
description: "Fresenius has established a new corporate venture capital unit, Fresenius Ventures, with an initial allocation of at least EUR 200 million for investments over the next five years. Thomas Michael Thestrup has been appointed as managing director to lead this new division. He joins from Angelini Ventures, bringing prior experience in corporate business development and strategy from Lundbeck and UCB."
datetime: "2026-07-23T08:03:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293578816.md)
  - [en](https://longbridge.com/en/news/293578816.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293578816.md)
generator: "portal-rs"
---

# Fresenius names Thomas Thestrup head of new Ventures unit

-   Fresenius created corporate venture capital unit Fresenius Ventures, earmarking at least EUR 200 million for investments over the next five years. \* Thomas Michael Thestrup appointed managing director to lead the new unit. \* Thestrup joins from Angelini Ventures; prior roles include director of corporate business development and strategy at Lundbeck, global business development at UCB. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fresenius SE & Co. KGaA published the original content used to generate this news brief on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [FSNUY.US](https://longbridge.com/en/quote/FSNUY.US.md)
- [FRE.DE](https://longbridge.com/en/quote/FRE.DE.md)
- [UCBJY.US](https://longbridge.com/en/quote/UCBJY.US.md)

## Related News & Research

- [Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S. | FSNUY Stock News](https://longbridge.com/en/news/297960064.md)
- [Fresenius Kabi launches generic sugammadex prefilled syringe in US](https://longbridge.com/en/news/297958888.md)
- [Fitch affirms Fresenius at BBB-, lifts outlook to positive](https://longbridge.com/en/news/295407662.md)
- [Fresenius SE & Co. (OTCMKTS:FSNUY) Short Interest Update](https://longbridge.com/en/news/296075339.md)
- [SGL Carbon publishes September 2026 IR presentation](https://longbridge.com/en/news/297654149.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**